Pure Global

Enhancing Lung Cancer Screening Through Human-Centered Intervention - Trial NCT06351085

Access comprehensive clinical trial information for NCT06351085 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Davis and is currently Recruiting. The study focuses on Lung Cancer. Target enrollment is 2869 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06351085
Recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06351085
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Enhancing Lung Cancer Screening Through Human-Centered Intervention

Study Focus

Lung Cancer

Pre-Visit Planner

Interventional

behavioral

Sponsor & Location

University of California, Davis

Sacramento, United States of America

Timeline & Enrollment

N/A

Nov 10, 2022

Apr 14, 2025

2869 participants

Primary Outcome

Lung Cancer Screening

Summary

The purpose of this study is to further understand the factors involved in increasing lung
 cancer screening.

ICD-10 Classifications

Carcinoma in situ: Bronchus and lung
Secondary malignant neoplasm of lung
Malignant neoplasm of bronchus and lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm: Overlapping lesion of bronchus and lung

Data Source

ClinicalTrials.gov

NCT06351085

Non-Device Trial